By: Kairos Ventures On: June 20, 2021 In: MemVerge, Portfolio News

The FUTR podcast spoke with MemVerge CEO Charles Fan: "Sandesh and I first met MemVerge’s founder and CEO, Charles,...

Read more
By: Kairos Ventures On: June 15, 2021 In: Linnaeus, Portfolio News

Linnaeus Therapeutics announced the expansion of its ongoing clinical collaboration with Merck to include multiple additional phase 2 cohorts....

Read more
By: Kairos Ventures On: June 11, 2021 In: Portfolio News, Provivi

Provivi® Inc. proudly announces three award wins for its video campaign collaboration with filmmaker Richard Goldgewicht at the 41st...

Read more
By: Kairos Ventures On: June 10, 2021 In: Neuro-Bio, Portfolio News

Baroness Susan Greenfield is, among other things, a scientist, author, broadcaster, member of the House of Lords and the...

Read more
By: Kairos Ventures On: June 9, 2021 In: DEARhealth, Portfolio News

DEARhealth announced that it has obtained certification for ISO 13485 (quality management systems for medical devices) and the certificate...

Read more
By: Kairos Ventures On: June 7, 2021 In: Linnaeus, Portfolio News

Linnaeus Therapeutics, Inc. announced the presentation of clinical data from its phase 1 dose-escalation study of LNS8801 as a...

Read more
By: Kairos Ventures On: June 3, 2021 In: MixComm, Portfolio News

MixComm announced the latest addition to its portfolio of breakthrough front-end ICs for 5G mmWave. The SUMMIT 3741 integrates...

Read more
By: Kairos Ventures On: May 25, 2021 In: Foldax, Portfolio News

Foldax announced the successful first-in-human use of its biopolymer Tria™ heart valve in surgically replacing a diseased mitral valve....

Read more

The approval clears the way for Kachlany’s company, Actinobac Biomed, to initiate a phase I clinical trial in patients...

Read more

Scientists at Sienza Energy in Pasadena, a Caltech spinoff, are developing two trendsetting batteries for electric vehicles and consumer...

Read more